Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program.
about
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare WorkersReproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.Incidence of occupational latent tuberculosis infection in South African healthcare workers.Diagnosis and treatment of latent tuberculosis infection: an update.Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers.The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South KoreaInterferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review.Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workersTest variability of the QuantiFERON-TB gold in-tube assay in clinical practiceThe effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisationEvaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan.Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis - a prospective cohort study.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Preventing the Transmission of Tuberculosis in Health Care Settings: Administrative Control.IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.Interferon-gamma release assays and the diagnosis of tuberculosis: have they found their place?Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country.Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.Finding Truth in Biased Results.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.Quantiferon TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents.A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testing.Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelinesOccupational Screening for Tuberculosis. A Testing Time for Interferon-γ Release Assays
P2860
Q21133739-C4F4B1AB-258C-44AF-946E-AD797185824EQ21296671-40610451-A465-4751-8A3F-442F1CC4972FQ33792760-B6A88269-8AF2-47DA-B554-E5A3620B1945Q33890563-076D7AA6-A68D-438D-9177-F6897B439372Q33924856-0D4C192B-A963-4A2C-878B-C512294A3280Q34290177-C90CC5B0-B77D-420F-B170-30802AD5557BQ34670617-E494549B-80B4-459F-A505-AFD1287B5E97Q34776030-22B3D4C5-B7C7-4A6B-897F-9DD47F8DD357Q34994271-8791ACA7-ACC3-40A3-ADB6-5ECC89E956C7Q36040080-C3BA67F3-15CD-4D70-8534-84A58224C830Q36161757-0AFD36F7-FA3C-4E8D-8037-5141B4E900D6Q36585190-FEE710D9-0670-442A-8DD9-BF7B4C417798Q36605086-36EB4569-AF8A-4DDB-B234-1179C9A5C27CQ36836585-C41CEF80-02D9-4C0A-A369-51D2F2116DC7Q37137247-950402B3-C37E-4B52-83CA-D7E81D5AB0C0Q37173974-B23FC9A4-F3E6-4047-8526-FE8FA00B5238Q37304401-8791FCC4-ADEB-4F55-8DBA-44623FCB60B8Q37378565-38B873E7-4ED3-4DFD-A054-E30CB30C0E37Q37544916-A733A705-05DF-407A-8041-EF745718EBB7Q37599991-91AE037E-F573-4CF4-8014-58E6CACC45FDQ38083313-01D2F5D2-C8A6-4E42-8B82-B93AF291FA53Q38180469-5919C24B-D66C-4376-98FD-B88EC8A3F02AQ38231682-CA493069-2FD1-4064-B0A1-0A53C1D355B7Q38670287-FDC06306-83AC-4208-9E63-D59758E852FBQ39875966-5E67FC64-4B7A-4A79-A210-A9A39BB7AB24Q40596209-CD937191-CC3E-43D4-9C70-C4CC3C0E13F8Q40897243-AF5DD735-3020-4AD5-B82E-9F82FFE464B0Q43196415-ECD3039D-9330-4147-A306-ABC67AA4A14FQ46018457-144D7C63-A489-4F2C-BF37-87FDF74B25ECQ47554066-C5225D47-580A-481D-A7B3-EA08CCF98F04Q48066031-9E74392D-C3F6-4E63-8A22-CCCB839591A1Q48154595-7885DD93-A282-4EE5-8465-7FEE0F1B1D69Q51221243-7414DC07-1384-4A4D-9770-4CD1DDB0D074Q58746309-5386C5C2-0079-4F73-A0C8-DBE7782C9D52Q59200599-6071B2EB-B839-43F6-9DC3-3885F39095B6
P2860
Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges of interferon-γ rel ...... rkers in a TB control program.
@en
type
label
Challenges of interferon-γ rel ...... rkers in a TB control program.
@en
prefLabel
Challenges of interferon-γ rel ...... rkers in a TB control program.
@en
P2093
P356
P1433
P1476
Challenges of interferon-γ rel ...... rkers in a TB control program.
@en
P2093
Belinda Yen-Lieberman
Cyndee Miranda
David van Duin
J Walton Tomford
Kimberlee S Fong
Lucileia Teixeira
Steve M Gordon
Thomas G Fraser
P356
10.1378/CHEST.11-0992
P407
P577
2012-07-01T00:00:00Z